Is coronavirus still a danger, even if I’m vaccinated? A new rapid test needs just 10 minutes to show whether you have had the intended immune response.

Levels of uncertainty are running high – especially after having heard from the Standing Committee on Vaccinations (German: STIKO) that, despite being fully vaccinated, some people are nevertheless not protected from coronavirus. Antibody tests can now be offered to provide certainty on the presence of an individual’s immune response. nal von minden, a medical-technology company from Moers in Germany, has developed a rapid test that can reliably detect antibodies against COVID-19 pathogens in blood within just 10 minutes. The NADAL COVID-19 S1-NAb Test is now available.

Particularly in people with a weak immune system or those with certain pre-existing conditions, it is possible that a coronavirus vaccination can prompt a poor immune response – or even none at all. Numerous studies indicate the low effectiveness of the vaccine in certain groups, says Prof. Dr. Thomas Mertens, chair of the Standing Committee on Vaccinations, in an interview with the Funke Media Group. Particularly affected are patients whose immune system is affected by medication, for example, following organ transplants, certain cancer treatments or autoimmune diseases such as diabetes or rheumatism.

In addition to this is the fact that the vaccines themselves don’t offer 100 percent protection from coronavirus. The proven efficacy – depending on the vaccine – lies between 65 and 95%. (Source: RKI, as of 1.6.2021, https://www.rki.de/SharedDocs/FAQ/COVID-Impfen/FAQ_Liste_Wirksamkeit.html).

“The protection offered from vaccines against coronavirus is unfortunately not as good as we would have hoped,” says Thomas Zander, CEO at nal von minden GmbH. Whether the vaccine has ‘worked’ in individual cases can be determined by the use of a new rapid test: The NADAL COVID-19 S1-NAb Test detects antibodies that have a potentially neutralising effect against the coronavirus, and so can protect against a COVID-19 infection.

Zander goes on to explain: “In order that a vaccinated person can be properly protected against coronavirus, antibodies must form in the blood following vaccination. These antibodies ensure that, should an individual come into contact with the virus, it would be immediately recognised and repelled. It is these antibodies that can be detected with our new rapid test.”

A tiny prick of the finger – half the size of what’s needed for monitoring blood sugar – is enough. The drop of blood is then added to the test cassette provided. Results are available within 10 minutes. The rapid test is only to be carried out by medical personnel – it is not for self-use.

If receiving a two-dose coronavirus vaccine, it is generally recommended to carry out the new rapid test at least 2 weeks after the first appointment. If the test is negative, it can be repeated two weeks after the second vaccination, and again any time thereafter. It is still how long the protection offered by vaccines lasts, or if a further dose is necessary.

Important information: For anybody who is interested in having a COVID-19 S1-NAb Test carried out, this can be done by your GP. Depending on the practice, this costs around €20. www.nal-vonminden.com

Hellwig PR
Gabriele Hellwig
Garstedter Weg 268
D- 22455 Hamburg
Tel.: +49 40 38 66 24 80
E-Mail: info@hellwig-pr.de
www.hellwig-pr.de

nal von minden GmbH, based in Moers, Germany, has been a specialist in the field of medical diagnostics for 38 years. Its portfolio includes rapid tests and laboratory tests for reliable diagnoses in the fields of bacteriology, cardiology, gynaecology, infectious diseases, urology and toxicology. nal von minden GmbH has a total of about 230 employees at 9 European locations. www.nal-vonminden.com

This release was published on openPR.